Showing results (411-420 of 523) with videos related to
Sort By:
Pageof 53
Therapeutic Advances in Musculoskeletal Disease|April 25, 2022
Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegolMegan Clowse, Rebecca Fischer-Betz, Catherine Nelson-Piercy, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 7, 2018
What is psoriasis? - Perception and assessment of psoriasis among the German populationRachel Sommer, Ulrich Mrowietz, Marc Alexander Radtke, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 7, 2018
Was ist Schuppenflechte? - Wahrnehmung und Bewertung der Psoriasis in der deutschen BevölkerungRachel Sommer, Ulrich Mrowietz, Marc Alexander Radtke, et al.Journal of Drugs in Dermatology : JDD|April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 StudiesMelinda J Gooderham, Boni Elewski, Matthias Augustin, et al.Frontiers in Medicine|May 22, 2023
Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measureRachael Pattinson, Nirohshah Trialonis-Suthakharan, Rachael M Hewitt, et al.The British Journal of Dermatology|January 4, 2022
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trialMatthias Augustin, Kristian Reich, Paul Yamauchi, et al.Acta Dermato-Venereologica|March 6, 2025
Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HSNatalia Kirsten, Matthias Augustin, Christine Blome, et al.Dermatology and Therapy|July 30, 2026
AD-REAL: A Prospective, Multinational, Observational Cohort Study of Clinical Effectiveness and Treatment Discontinuation of Oral Systemics for Moderate-to-Severe Atopic DermatitisMatthias Augustin, Andreas Pinter, Silvia Sabatino, et al.Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|February 17, 2021
Assessing the quality of life of people with chronic wounds by using the cross-culturally valid and revised Wound-QoL questionnaireCatharina C von Stülpnagel, Neuza da Silva, Matthias Augustin, et al.Plos One|May 26, 2018
Willingness to pay for a cure of low-risk melanoma patients in GermanyMatthias Augustin, Christine Blome, Andrea Forschner, et al.Pageof 53